ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,521Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 98

$3.01M Total Retail Price of All Prescriptions

Rank: 1 out of 98

613 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 613 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

16% of this provider’s 613 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 19,537 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

67% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$123 was the average price of a prescription from this provider, compared to $73 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
ZETIA 1,177 929 10 1 37
BYSTOLIC 777 653 2 51
NEXIUM 760 523 3 14
OMEPRAZOLE 667 563 4 3
CRESTOR 635 494 5 18
GABAPENTIN 628 560 6 19
DIOVAN HCT 603 485 7 46
SINGULAIR 530 414 8 43
ATELVIA 517 404 9 98
EXELON 408 408 10 78
METFORMIN HCL 407 316 11 4
SYNTHROID 399 338 12 29
LOVAZA 391 309 13 32
EPIPEN 2-PAK 390 264 10 14 118
NAMENDA 388 388 15 28
ENABLEX 386 342 10 16 106
TRICOR 370 285 17 76
FLUTICASONE PROPIONATE 362 260 18 38
VIIBRYD 358 255 10 19 122
JANUMET 345 283 20 110
ZOLPIDEM TARTRATE 328 246 21 12
VOLTAREN 310 243 22 42
RANEXA 303 266 23 111
LUNESTA 273 177 10 24 144
AMLODIPINE BESYLATE 266 234 25 2
METOPROLOL SUCCINATE 261 244 26 11
SAVELLA 259 160 10 27 151
EXFORGE HCT 239 210 10 28 155
BENICAR HCT 238 188 29 120
MECLIZINE HCL 238 187 29 67
FUROSEMIDE 231 225 31 8
RANITIDINE HCL 215 181 32 22
AMMONIUM LACTATE 212 176 33 30
SIMVASTATIN 206 182 34 1
PROLIA 198 183 10 35 163
TRIBENZOR 194 177 36 166
MONTELUKAST SODIUM 187 145 37 102
ADVAIR DISKUS 187 119 37 47
CLOTRIMAZOLE-BETAMETHASONE 184 126 39 93
DALIRESP 174 156 40 180
HYDROCODONE-ACETAMINOPHEN 164 131 S3 41 36
ALVESCO 142 109 10 42 204
ATORVASTATIN CALCIUM 139 124 43 10
HYDROCHLOROTHIAZIDE 136 99 44 9
TRIANEX 136 89 10 44 209
BYDUREON 131 97 46 213
GLIPIZIDE 129 108 47 85
ACTOS 127 107 48 101
PENNSAID 126 105 49 156
POLYETHYLENE GLYCOL 3350 126 108 49 52
NAPROXEN 125 89 51 134
NAPRELAN 122 89 10 52 219
LISINOPRIL 119 107 53 6
CEFUROXIME 117 87 54 224
VESICARE 113 105 55 159
QUETIAPINE FUMARATE 112 86 56 40
EXFORGE 112 89 56 178
VYTORIN 112 88 56 186
MELOXICAM 111 66 59 31
DIOVAN 111 105 59 25
PATADAY 109 83 61 58
CARVEDILOL 106 100 62 23
JALYN 105 99 63 233
CELEBREX 101 57 64 66
LANTUS 99 73 65 64
WELCHOL 98 85 66 239
SYMBICORT 97 49 67 138
OMNARIS 92 48 10 68 244
SEROQUEL XR 91 59 69 245
AZITHROMYCIN 90 69 70 49
NASONEX 89 76 71 154
CLOPIDOGREL 88 83 72 34
LIDODERM 87 61 73 87
PROAIR HFA 85 58 74 62
CIPRODEX 85 55 74 255
CYMBALTA 83 58 76 72
PRANDIN 82 82 77 258
WARFARIN SODIUM 82 78 77 13
FORTEO 81 79 79 260
LOSARTAN-HYDROCHLOROTHIAZIDE 77 63 80 45
LOSARTAN POTASSIUM 77 72 80 15
BENICAR 76 46 82 216
VALSARTAN-HYDROCHLOROTHIAZIDE 74 48 83 267
DICLOFENAC SODIUM 73 70 84 60
DIGOXIN 73 73 84 80
GLYBURIDE 71 51 R 86 71
ATENOLOL 69 60 87 16
ALENDRONATE SODIUM 68 59 88 17
BYETTA 68 32 88 220
SOLARAZE 67 61 90 105
EVISTA 66 59 91 74
ESCITALOPRAM OXALATE 64 57 92 126
PLAVIX 64 59 92 40
LEVOTHYROXINE SODIUM 64 55 92 7
TAMSULOSIN HCL 64 54 92 20
TRILIPIX 63 43 96 178
TRIAMCINOLONE ACETONIDE 63 55 96 123
CIPROFLOXACIN HCL 61 49 98 83
AMLODIPINE BESYLATE-BENAZEPRIL 59 47 99 63
ISOSORBIDE MONONITRATE ER 57 54 100 73
SEROQUEL 55 47 101 109
OXYCODONE-ACETAMINOPHEN 53 11 S2 102 136
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.